{
    "title": "Reata shares triple after surprise FDA nod for rare disease drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11808195/Reata-shares-hit-1-year-high-surprise-FDA-nod-rare-disease-drug.html",
    "date": "2023-03-01",
    "keywords": [
        "drug",
        "approval",
        "reata",
        "fda",
        "analyst",
        "march",
        "value",
        "wednesday",
        "food",
        "administration",
        "uncertainty",
        "future",
        "record",
        "oneday",
        "volume",
        "stock",
        "skyclarys",
        "treatment",
        "ataxia",
        "disorder",
        "damage",
        "system",
        "death",
        "companys",
        "product",
        "forth",
        "regulator",
        "midstage",
        "trial",
        "review",
        "joseph",
        "schwartz",
        "surprise",
        "agencys",
        "nod",
        "muscle",
        "exondys",
        "biogen",
        "aduhelm",
        "leadership",
        "agency",
        "monday",
        "resignation",
        "possibility",
        "division",
        "head",
        "past",
        "odyssey",
        "hall",
        "fame",
        "brian",
        "company",
        "acquisition",
        "cost",
        "aditya",
        "samal",
        "bengaluru",
        "editing",
        "shweta",
        "agarwal",
        "venkateshwaran",
        "richard",
        "chang"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}